E-LIB Suche - Ergebnisse für: Bose, Prithviraj

1

Safety and efficacy of luspatercept for the treatment of an..:

Gerds, Aaron T. ; Harrison, Claire N. ; Kiladjian, Jean-Jacques...
Blood Advances. , 2024

Link: https://doi.org/10.1182/..

2

Reduced dose azacitidine plus venetoclax as maintenance the..:

Bazinet, Alexandre ; Kantarjian, Hagop ; Bataller, Alex...
The Lancet Haematology. 11 (2024) 4 - p. e287-e298 , 2024

Link: https://doi.org/10.1016/..

3

Interferons in the treatment of myeloproliferative neoplasm:

Vachhani, Pankit ; Mascarenhas, John ; Bose, Prithviraj...
Therapeutic Advances in Hematology. 15 (2024) - p. , 2024

Link: https://doi.org/10.1177/..

4

Sotatercept for anemia of myelofibrosis: a phase II investi..:

Bose, Prithviraj ; Masarova, Lucia ; Pemmaraju, Naveen...
Haematologica. , 2024

Link: https://doi.org/10.3324/..

5

SOHO State of the Art Updates and Next Questions | Diagnosi..:

Vachhani, Pankit ; Loghavi, Sanam ; Bose, Prithviraj
Clinical Lymphoma Myeloma and Leukemia. , 2024

Link: https://doi.org/10.1016/..

6

Prospective performance of the IWG-2023 criteria and IPSS-M..:

Urrutia, Samuel ; Bose, Prithviraj ; Alvarado, Yesid...
Blood Neoplasia. 1 (2024) 2 - p. 100008 , 2024

Link: https://doi.org/10.1016/..

7

A randomized, double-blind study of zinpentraxin alfa in pa..:

Verstovsek, Srdan ; Talpaz, Moshe ; Wadleigh, Martha...
Haematologica. , 2024

Link: https://doi.org/10.3324/..

8

Exploring the landscape of somatic ASXL2 mutations in myelo..:

Abuasab, Tareq ; Borthakur, Gautam ; Kanagal‐Shamanna, Rashmi...
American Journal of Hematology. 99 (2024) 7 - p. 1434-1436 , 2024

Link: https://doi.org/10.1002/..

9

Multicolor flow cytometric immunophenotyping is highly sens..:

Nwogbo, Okechukwu Valentine ; Fang, Hong ; Wang, Wei...
American Journal of Clinical Pathology. 161 (2024) 6 - p. 598-608 , 2024

Link: https://doi.org/10.1093/..

10

Disseminated Histoplasmosis in a Patient with Myelofibrosis..:

Chiu, Chia-Yu ; John, Teny ; Matsuo, Takahiro...
Journal of Fungi. 10 (2024) 4 - p. 264 , 2024

Link: https://doi.org/10.3390/..

11

Initial Results from Summit: An On-going, 3-Part, Multi-Cen..:

Modena, Brian ; Rein, Lindsay A.M. ; Oh, Stephen...
Journal of Allergy and Clinical Immunology. 153 (2024) 2 - p. AB224 , 2024

Link: https://doi.org/10.1016/..

12

Reductions in Polypharmacy for Patients with Indolent Syste..:

Akin, Cem ; Gotlib, Jason ; Alvarez-Twose, Ivan...
Journal of Allergy and Clinical Immunology. 153 (2024) 2 - p. AB225 , 2024

Link: https://doi.org/10.1016/..

13

Management of Patients with Early Myelofibrosis: A Discussi..:

Bose, Prithviraj
Current Hematologic Malignancy Reports. 19 (2024) 3 - p. 111-119 , 2024

Link: https://doi.org/10.1007/..

14

Complex I inhibitor of oxidative phosphorylation in advance..:

Yap, Timothy A. ; Daver, Naval ; Mahendra, Mikhila...
Nature Medicine. , 2023

Link: https://doi.org/10.1038/..

15

MPN-404 Safety and Efficacy of Luspatercept for the Treatme..:

Gerds, Aaron T. ; Harrison, Claire ; Kiladjian, Jean-Jacques...
Clinical Lymphoma Myeloma and Leukemia. 23 (2023) - p. S393 , 2023

Link: https://doi.org/10.1016/..